GGrantIndex
← Leaderboards

Ellen M. Zimmermann

University Of Michigan At Ann Arbor

$3,167,259
Attributed
$3,167,259
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $404.2K · FY200511
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$3,167,259 · 6

By mechanism

R01$3,098,535 · 2
M01$68,724 · 4

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationCollagenFibrosisClinical ResearchEndoscopyClinical TrialsHistopathologyInstitutionPharmaceutical PreparationsTissuesMonitorCrohn'S DiseaseEvaluationResearch PersonnelCicatrixChronic3-DimensionalCharacteristicsBaseDisease ProgressionEarly TreatmentCrohn&AposCapsule (Pharmacologic)Detection

Grant awards (17)

Detection of inflammation vs. intestinal fibrosis in Crohn's disease$298,184
R01 · FY2011 · DK · contact PI
Detection of inflammation vs. intestinal fibrosis in Crohn's disease$301,196
R01 · FY2010 · DK · contact PI
Detection of inflammation vs. intestinal fibrosis in Crohn's disease$304,239
R01 · FY2009 · DK · contact PI
Detection of inflammation vs. intestinal fibrosis in Crohn's disease$100,000
R01 · FY2009 · DK · contact PI
Detection of inflammation vs. intestinal fibrosis in Crohn's disease$304,239
R01 · FY2008 · DK · contact PI
Detection of inflammation vs. intestinal fibrosis in Crohn's disease$310,448
R01 · FY2007 · DK · contact PI
LIPITOR IN THE TREATMENT OF ULCERATIVE COLITIS$1,808
M01 · FY2007 · RR · contact PI
LIPITOR IN THE TREATMENT OF ULCERATIVE COLITIS$21,461
M01 · FY2006 · RR · contact PI
IGF-I AND IGFBP-5 IN INTESTINAL FIBROSIS$295,981
R01 · FY2005 · DK
LIPITOR IN THE TREATMENT OF ULCERATIVE COLITIS$42,716
M01 · FY2005 · RR
IGF-I AND IGFBP-5 IN INTESTINAL FIBROSIS$295,981
R01 · FY2004 · DK
Dietary Zinc Supplementation in Patients w/Crohn's Disease$2,542
M01 · FY2004 · RR
IGF-I AND IGFBP-5 IN INTESTINAL FIBROSIS$295,981
R01 · FY2003 · DK
IGF-I AND IGFBP-5 IN INTESTINAL FIBROSIS$295,981
R01 · FY2002 · DK
OCTREOTIDE (SANDOSTATIN) IN TREATMENT OF PATIENTS W/ ACTIVE CROHNS DISEASE$0
M01 · FY2002 · RR
IGF-I AND IGFBP-5 IN INTESTINAL FIBROSIS$296,305
R01 · FY2001 · DK
OCTREOTIDE (SANDOSTATIN) IN TREATMENT OF PATIENTS W/ ACTIVE CROHNS DISEASE$197
M01 · FY2000 · RR